Background Ivacaftor (IVA) has been shown to improve lung function and other clinical outcomes in people with cystic fibrosis (CF). A decade of real-world IVA availability has enabled the examination ...
With a whole range of new functions that make it easier for developers to debug and perform trace-based analysis of complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback